http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_294748649cde266f2197e156d339bfc9
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | J. Nutt Nutt |
| name | David J. Nutt David J Nutt |
| given-name | David J David J. David |
| organization-name | NIAAA 9000 Rockeville Pike, Bethesda, Maryland 20205, USA Division of Brain Sciences Imperial College London Du Cane Road London W12 0NN United Kingdom Division of Experimental Medicine, Neuropsychopharmacology Unit, Imperial College London, London, UK Neuropsychopharmacology Unit, Imperial College London, UK Division of Brain Sciences; Department of Medicine; Centre for Neuropsychopharmacology; Imperial College London; United Kingdom Division of Experimental Medicine, Imperial College London, London, UK, University of Bristol, Psychopharmacology Unit, Dorothy Hodgkin Building, Bristol, UK, Department of Neuropsychopharmacology and Molecular Imaging, Imperial College London, London, UK. Neuropsychopharmacology Unit, Centre for Pharmacology and Therapeutics, Division of Experimental Medicine, Imperial College London, London, UK. University of Bristol, Psychopharmacology Unit, Dorothy Hodgkin Building, Bristol UK, Psychopharmacology Unit, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 1 TD, UK Imperial College London Centre for Neuropsychopharmacology London UK Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, United Kingdom. Bristol, UK Psychopharmacology Unit, University of Bristol, Bristol BS1 3NY, UK Psychopharmacology Unit, University of Bristol, Bristol, UK. Imperial College London Hammersmith Hospital London UK Centre for Psychedelic Research, Department of Brain Sciences, Imperial College London, London SW7 2AZ, U.K. Department of Medicine, Centre for Psychedelic Research, Imperial College, London, United Kingdom. Psychopharmacology Unit, University of Bristol, Bristol, UK; Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK The Psychopharmacology Unit, School of Medical Sciences, University of Bristol, University Walk, Bristol BS8 ITD, UK Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK.; Psychopharmacology Unit, University of Bristol, Bristol, UK. Imperial College London UK Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK Division of Experimental Medicine, Neuropsychopharmacology Unit, Imperial College London, Burlington Danes Building, London, UK Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London, London, UK Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, Burlington Danes Building Du Cane Road London United Kingdom Neuropsychopharmacology Unit, Imperial College London, London, UK Centre for Neuropsychopharmacology, Imperial College London, United Kingdom Department of Psychiatry, Division of Brain Science, Imperial College, London, UK Neuropsychopharmacology Unit, Imperial College London, UK, Division of Brain Sciences Centre for Neuropsychopharmacology, Imperial College London W12 0NN London United Kingdom Centre for Academic Psychiatry, Imperial College, Hammersmith Hospital, London, United Kingdom Centre for Neuropsychopharmacology, Division of Brain Sciences Imperial College London UK Centre for Neuropsychopharmacology, Imperial College London, London, UK; DrugScience, London, UK Psychopharmacology Unit, School of Medical Sciences, Bristol From the Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London. Centre for Psychedelic Research, Division of Academic Psychiatry, Imperial College London, London, UK Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, UK Department of Medicine Imperial College London London UK Reckitt & Colman Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol BS8 ITD, UK Neuropsychopharmacology Unit,; Academic Unit of Psychiatry, University of Bristol, Bristol BS8 2BN, United Kingdom; Centre for Neuropsychopharmacology Imperial College London London UK Imperial College London, Division of Neurosciences and Mental Health, London, UK Neuropsychopharmacology Unit, Division of Brain Sciences, Imperial College London, London, UK Centre for Psychedelic Research, Department of Medicine, Imperial College London, London, UK Centre for Neuropsychopharmacology, Department of Medicine, Imperial College London, W12 0NN, London, United Kingdom; Department of Neuropsychopharmacology and Molecular Imaging, Division of Neuroscience & Mental Health, Imperial College London, London, UK Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine Imperial College London UK Centre for Neuropsychopharmacology, Imperial College London LondonUK Psychopharmacology Unit, University of Bristol,Bristol, United Kingdom. david.j.nutt@bristol.ac.uk Neuropsychopharmacology Unit, Division of Experimental Medicine Imperial College London UK Department of Neuropsychopharmacology and Molecular Imaging, Imperial College London, London, UK, Neuropsychopharmacology Unit Centre for Psychiatry Imperial College London London UK Imperial College London, Hammersmith Hospital, London, UK Psychopharmacology Unit, School of Medical Science, University of Bristol, Bristol, U.K. University of Bristol, Bristol, United Kingdom. david.j.nutt@bristol.ac.uk Imperial College, London, UK. Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol, UK. david.j.nutt@bristol.ac.uk Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol, UK Centre for Neuropsychopharmacology, Department of Medicine Imperial College London London W12 0NN United Kingdom Faculty of Medicine, Imperial College London, London, UK Department of Brain Sciences, Imperial College London, Hammersmith Hospital , London , UK Psychopharmacology Unit, University of Bristol, School of Medical Sciences, University Walk, Bristol BS8 1 TD, UK University Department of Psychiatry, Warneford Hospital, Oxford, UK Centre for Neuropsychopharmacology Imperial College London UK University of Bristol Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol BS8 1 TD, UK Imperial College London, Centre for Neuropsychopharmacology, Division of Brain Sciences, Faculty of Medicine, London, UK; Drug Science, London, UK Drug Science, London, UK; Department of Brain Sciences, Imperial College London, London, UK Drug Science, St Peter’s House, London, UK; Neuropsychopharmacology Unit, Centre for Psychiatry, Imperial College London, London, UK Department of Neuropsychopharmacology, Imperial College London, London, UK, Division of Neurosciences and Mental Health, Imperial College London, London, UK Psychopharmacology Unit, University of Bristol, Bristol, UK Neuropsychopharmacology Unit, Imperial College, London, UK. d.nutt@imperial.ac.uk University of Bristol, Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol, UK. Division of Brain Sciences, Imperial College, Neuropsychopharmacology, London, UK; British Association for Psychopharmacology Council Member, UK Psychopharmacology Unit, University of Bristol, Bristol, UK, Centre for Neuropsychopharmacology, Imperial College London , W12 0NN, London , United Kingdom The Edmond J Safra Chair in Neuropsychopharmacology, Department of Neuropsychopharmacology and Molecular Imaging, Imperial College London, London, UK. Department of Community Based Medicine, Psychopharmacology Unit, University of Bristol, U.K. Psychopharmacology Unit, University of Bristol, Bristol, England Reckitt & Colman Psychopharmacology Unit, Department of Pharmacology, School of Medical Sciences, University Walk, Bristol BS8 1TD, UK Psychopharmacology Unit, University of Bristol, Dorothy Hodgkin Building, Bristol, UK Psychopharmacology Unit, Dorothy Hodgkin Building, University of Bristol, Bristol, UK Psychopharmacology Unit, University of Bristol, Bristol BS8 1TD, U.K., Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, U.K., Neurobiology Unit, Roche Bioscience, Palo Alto, California 94304-1397, School of Chemistry, University of Bristol, Bristol BS8 1TS, U.K., and School of Biological Sciences, University of Southampton, Bassett Crescent East SO16 7PX, U.K. Division of Brain Sciences, Department of Medicine, Imperial College London, London, UK The Psychopharmacology Unit, School of Medical Sciences, University of Bristol, Bristol BS8 1TD Centre for Neuropsychopharmacology, Imperial College London, London, UK Department of Brain Sciences Imperial College London, Hammersmith Hospital London UK Department of Psychopharmacology, School of Medical Sciences, University of Bristol, Bristol BS8 1TD, UK University of Bristol, United Kingdom Psychopharmacology Unit, The Medical School, University of Bristol BS8 ITN, UK University of Bristol, Psychopharmacology Unit School of Medical Sciences, University Walk, Bristol BS8 1TD, UK Psychopharmacology Unit, University of Bristol, United Kingdom. david.nutt@bristrol.ac.uk Division of Experimental Medicine, Imperial College London, London, UK Faculty of Medicine, Division of Brain Sciences, Imperial College London, London, UK Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK. Neuropsychopharmacology Unit, Department of Brain Sciences, Faculty of Medicine, Imperial College London, London, UK Imperial College London, London, UK Centre for Psychedelic Research, Department of Brain Sciences, Faculty of Medicine, Imperial College London , London, SW7 2AZ , UK Centre for Psychedelic Research, Imperial College London, London, UK Imperial College, London, London, UK Centre for Neuropsychopharmacology Division of Brain Sciences Hammersmith Hospital, Imperial College London W12 0NN United Kingdom Neuropsychopharmacology Unit, Division of Experimental Medicine, Imperial College London, London, UK Psychopharmacology Unit University of Bristol Department of Brain Sciences, Imperial College London, London, UK Neuropsychopharmacology Unit, Hammersmith Hospital Imperial College London London UK University of Bristol, Psychopharmacology Unit, Dorothy Hodgkin Building, Bristol, UK Reckitt and Colman Psychopharmacology Unit, School of Medical Sciences, Bristol Reckitt and Colman Psychopharmacology Unit, Medical School, Bristol, UK. Centre for Psychedelic Research, Division of Psychiatry, Department of Brain Sciences, Imperial College London, London, United Kingdom |
Incoming Links
Total number of triples: 562.